China Chemical Synthesis Biotechnology Co., Ltd. Q4 2025 EPS -NT$4.39
NQ Score
43/100
N1 Content Completeness
3
AI Summary (NQ-processed)
China Chemical Synthesis Biotechnology Co., Ltd. (1762) reported its Q4 2025 financial results, with basic earnings per share (EPS) at -NT$4.39. The company's revenue was NT$805 million, and net loss after tax was NT$244 million.
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is China Chemical Synthesis Biotechnology's stock code?
- A: China Chemical Synthesis Biotechnology's stock code is 1762.
- Q: What industry does China Chemical Synthesis Biotechnology belong to?
- A: China Chemical Synthesis Biotechnology belongs to the biotechnology and healthcare industry.
- Q: What were China Chemical Synthesis Biotechnology's Q4 2025 earnings per share?
- A: China Chemical Synthesis Biotechnology's Q4 2025 basic earnings per share (EPS) were -NT$4.39.
- Q: What was China Chemical Synthesis Biotechnology's revenue in Q4 2025?
- A: China Chemical Synthesis Biotechnology's revenue in Q4 2025 was NT$805 million.
- Q: What was China Chemical Synthesis Biotechnology's net loss after tax in Q4 2025?
- A: China Chemical Synthesis Biotechnology's net loss after tax in Q4 2025 was NT$244 million.